Global value chains, import orientation, and the state: South Africa’s pharmaceutical industry
Tóm tắt
As opposed to the predominant focus of global value chain (GVC) research on export-oriented contexts, this article examines the prospects for development in places where the dominant form of engagement with GVCs is import-oriented. Through the case of South Africa’s pharmaceutical industry, this analysis demonstrates the challenge for local manufacturing to compete, and the associated state policy responses, in a place which is largely plugged into GVCs as an end market rather than as a production location. As multinationals have concentrated production elsewhere, South Africa’s manufacturing capacity in the pharmaceutical industry has relatively declined in recent decades. Having struggled in its facilitator role, the South African state’s efforts to promote local manufacturing have turned to the producer role through a state-owned company and especially the buyer role through public procurement. Motivations for state policy in this context, however, must navigate the tension which sometimes exists between the industrial interest in local manufacturing and the consumer and health policy interest in access to medicines. The experience of South Africa’s pharmaceutical industry points to the wider challenge and consequences of import-oriented engagement with GVCs for local industrial development.
Từ khóa
Tài liệu tham khảo
Alford, M., & Phillips, N. 2018. The political economy of state governance in global production networks: Change, crisis and contestation in the South African fruit sector. Review of International Political Economy, 25(1): 98–121.
Altenburg, T. 2006. Governance patterns in value chains and their development impact. The European Journal of Development Research, 18(4): 498–521.
Aspen. 2005. Impressive growth prospects for Aspen. Supplement to Modern Pharmacy, 12(3): 33–38.
Aspen. 2010. Invitation to address parliamentary portfolio committee of trade and industry on IPAP2: Submission to Parliament by Aspen Pharmacare Holdings Ltd. http://pmg-assets.s3-website-eu-west-1.amazonaws.com/docs/100310aspen-edit.pdf. Accessed 14 June 2019.
Athreye, S., Kale, D., & Ramani, S. 2009. Experimentation with strategy and the evolution of dynamic capability in the Indian pharmaceutical sector. Industrial and Corporate Change, 18(4): 729–759.
Autor, D., Dorn, D., & Hanson, G. 2013. The China syndrome: Local labor market effects of import competition in the United States. The American Economic Review, 103(6): 2121–2168.
Bair, J. 2005. Global capitalism and commodity chains: Looking back, going forward. Competition and Change, 9(2): 153–180.
Bair, J., & Werner, M. 2011. The place of disarticulation: Global commodity production in La Laguna, Mexico. Environment and Planning A, 43(5): 998–1015.
Baldwin, R. 2016. The Great Convergence: Information technology and the new globalization. Belknap: Cambridge, MA.
Barbieri, P., Elia, S., Fratocchi, L., Kalchschmidt, M., & Samson, D. 2020. What can we learn about reshoring after Covid-19? Operations Management Research, 13: 131–136.
Barrientos, S., Gereffi, G., & Rossi, A. 2011. Economic and social upgrading in global production networks: A new paradigm for a changing world. International Labour Review, 150(3–4): 319–340.
Bartley, T. 2018. Rules without rights: Land, labor, and private authority in the global economy. Oxford: Oxford University Press.
Blažek, J. 2016. Towards a typology of repositioning strategies of GVC/GPN suppliers: The case of functional upgrading and downgrading. Journal of Economic Geography, 16(4): 849–869.
BMI Research. 2019. South Africa Pharmaceuticals and Healthcare Report 2020 Q1. BMI Research.
Bolton, P. 2006. Government procurement as a policy tool in South Africa. Journal of Public Procurement, 6(3): 193–217.
Buckley, P., & Strange, R. 2015. The governance of the global factory: Location and control of world economic activity. The Academy of Management Perspectives, 29(2): 237–249.
Chandler, A. D. 2005. Shaping the industrial century: The remarkable story of the evolution of the modern chemical and pharmaceutical industries. Cambridge, MA: Harvard University Press.
Chaudhuri, S. 2005. The WTO and India’s pharmaceutical industry: Patent protection, TRIPs and developing countries. New Delhi: Oxford University Press.
Chaudhuri, S., Mackintosh, M., & Mujinja, P. 2010. Indian generics producers, access to essential medicines and local production in Africa: An argument with reference to Tanzania. European Journal of Development Research, 22(4): 451–468.
Chorev, N. 2019. Give and take: Developmental foreign aid and the pharmaceutical industry in East Africa. Princeton: Princeton University Press.
Coe, N., Dicken, P., & Hess, M. 2008. Global production networks: Realizing the potential. Journal of Economic Geography, 8(3): 271–295.
Coe, N., Hess, M., Yeung, H., Dicken, P., & Henderson, J. 2004. “Globalizing” regional development: A global production networks perspective. Transactions of the Institute of British Geographers, 29(4): 468–484.
Coe, N., & Yeung, H. 2015. Global production networks: Theorizing economic development in an interconnected world. Oxford: Oxford University Press.
Cuervo-Cazurra, A., Inkpen, A., Musacchio, A., & Ramaswamy, K. 2014. Governments as owners: State-owned multinational companies. Journal of International Business Studies, 45(8): 919–942.
Curran, L., Nadvi, K., & Campling, L. 2019. The influence of tariff regimes on global production networks (GPNs). Journal of Economic Geography, 19(4): 873–895.
Davenport-Hines, R. P. T., & Slinn, J. 1992. Glaxo: A history to 1962. Cambridge: Cambridge University Press.
De Marchi, V., Di Maria, E., Krishnan, A., & Ponte, S. 2019. Environmental upgrading in global value chains. In S. Ponte, G. Gereffi, & G. Raj-Reichert (Eds.), Handbook on Global Value Chains. Cheltenham: Edward Elgar.
Deloitte. 2007. The economic & socio-economic benefits of R&D-based multinational pharmaceuticals on the South African economy, Deloitte. Available from: http://ipasa.co.za/Downloads/IPASA%20and%20Pharmaceutical%20Industry%20Profile/Research%202007/IMSA%20Book%20071013.pdf.
Dicken, P. 1994. Global-local tensions: Firms and states in the global space-economy. Economic Geography, 70(2): 101–128.
Dong, J., & Mirza, Z. 2016. Supporting the production of pharmaceuticals in Africa. Bulletin of the World Health Organization, 94(1): 71–72.
DTI. 2007. Industrial Policy Action Plan (IPAP) 2007. Pretoria: Department of Trade and Industry.
DTI. 2011. The South African pharmaceutical sector profile for the consideration of designation of pharmaceutical products in terms of the PPFA. Pretoria: Department of Trade and Industry.
DTI. 2012. Media Statement by the South African Government on the Establishment of a Pharmaceutical Manufacturing Plant in South Africa. Pretoria: Department of Trade and Industry. 10th February.
DTI. 2014. Industrial policy action plan: Economic sectors and employment cluster IPAP 2014/15–2016/17. Pretoria: Department of Trade and Industry.
DTI. 2016. South Africa lands R1.3 billion pharmaceutical’s investment at Dube Trade Port (DTP) in KwaZulu-Natal. Pretoria: Department of Trade and Industry.
DTI. 2017. The DTI’s involvement in the State’s procurement of ARVs. Pretoria: Department of Trade and Industry.
DTI. 2018. Industrial Policy Action Plan 2018/19-2020/21. Pretoria: Department of Trade and Industry.
Edwards, L., & Jenkins, R. 2015. The impact of Chinese import penetration on the South African manufacturing sector. The Journal of Development Studies, 51(4): 447–463.
Evenett, S. J. 2019. Protectionism, state discrimination, and international business since the onset of the Global Financial Crisis. Journal of International Business Policy, 2(1): 9–36.
Focus Reports 2006. South African Report. Available from: www.focusreports.net. Accessed 14 July 2014.
Focus Reports. 2012. South Africa Pharma Report. Available from: www.pharma.focusreports.net. Accessed 14 July 2014.
Fridge. 2000. Pharmaceutical sector study. South Africa: Fund for Research into Industrial Development Growth and Equity.
Gelb, S. 2014. South Africa’s foreign direct investment links with the BRIC countries, SECO/WTI Academic Cooperation Project Working Paper Series 2014/10. Available at: http://dx.doi.org/10.2139/ssrn.2614350.
Gereffi, G. 1983. Dependency theory and the pharmaceutical industry in the third world. Princeton, NJ: Princeton University Press.
Gereffi, G. 1994. The organization of buyer-driven global commodity chains: How U.S. retailers shape overseas production networks. In G. Gerrefi & M. Korzeniewicz (Eds.), Commodity chains and global capitalism. Westport, CN: Praeger.
Gereffi, G. 1999. International trade and industrial upgrading in the apparel commodity chain. Journal of International Economics, 48(1): 37–70.
Gereffi, G. 2014. Global value chains in a post-Washington Consensus world. Review of International Political Economy, 21(1): 9–37.
Gereffi, G. 2019. Global value chains and international development policy: Bringing firms, networks and policy-engaged scholarship back in. Journal of International Business Policy, 2(3): 195–210.
Gereffi, G., Humphrey, J., & Sturgeon, T. 2005. The governance of global value chains. Review of International Political Economy, 12(1): 78–104.
Gibbon, P., & Ponte, S. 2005. Trading down: Africa, value chains and the global economy. Philadelphia: Temple University Press.
Giuliani, E., Pietrobelli, C., & Rabellotti, R. 2005. Upgrading in global value chains: Lessons from Latin American clusters. World Development, 33(4): 549–573.
Government of South Africa. 1996. National drug policy for South Africa. Pretoria: National Department of Health.
Gray, A., Suleman, F., & Pharasi, P. 2017. South Africa’s National Drug Policy: 20 years and still going? South African Health Review, 2017: 49–58.
Haakonsson, S. J. 2009. ‘Learning by importing’ in global value chains: Upgrading and South-South strategies in the Ugandan pharmaceutical industry. Development Southern Africa, 26(3): 499–516.
Hahn, S. & A. Shah. 2020. Op-ed: The coronavirus pandemic underscores the need to bring drug manufacturing back to U.S. CNBC.com, September 10. Available from: https://www.cnbc.com/2020/09/10/op-ed-the-coronavirus-pandemic-underscores-the-need-to-bring-drug-manufacturing-back-to-us.html. Accessed 11 September 2020.
Hauge, J. 2020. Industrial policy in the era of global value chains: Towards a developmentalist framework drawing on the industrialisation experiences of South Korea and Taiwan. The World Economy, 43(8): 2070–2092.
Haugen, H. Ø. 2018. Petty commodities, serious business: The governance of fashion jewellery chains between China and Ghana. Global Networks, 18(2): 307–325.
Helen Suzman Foundation. 2018. The supply of pharmaceuticals in South Africa. Johannesburg: Helen Suzman Foundation.
Henderson, J., Dicken, P., Coe, N., Hess, M., & Yeung, H. 2002. Global production networks and the analysis of economic development. Review of International Political Economy, 9(3): 436–464.
Hernández, V., & Pedersen, T. 2017. Global value chain configuration: A review and research agenda. BRQ Business Research Quarterly, 20(2): 137–150.
Horner, R. 2014. Strategic decoupling, recoupling and global production networks: India’s pharmaceutical industry. Journal of Economic Geography, 14(6): 1117–1140.
Horner, R. 2015. Responding to the rising power “threat”: pharmaceutical MNEs and the intellectual property “institutional void”. Critical Perspectives on International Business, 11(3/4): 285–300.
Horner, R. 2017. Beyond facilitator? State roles in global value chains and global production networks. Geography Compass, 11(2): e12307.
Horner, R., & Alford, M. 2019. The roles of the state in global value chains. In S. Ponte, G. Gereffi, & G. Raj-Reichert (Eds.), Handbook on Global Value Chains. Cheltenham: Edward Elgar.
Horner, R., & Murphy, J. T. 2018. South-North and South-South production networks: Diverging socio-spatial practices of Indian pharmaceutical firms. Global Networks, 18(2): 326–351.
Hughes, A., Morrison, E., & Ruwanpura, K. N. 2019. Public sector procurement and ethical trade: Governance and social responsibility in some hidden global supply chains. Transactions of the Institute of British Geographers, 44(2): 242–255.
Humphrey, J., & Schmitz, H. 2002. How does insertion in global value chains affect upgrading in industrial clusters? Regional Studies, 36(9): 1017–1027.
Irwin, D. 2021. The rise and fall of import substitution. World Development, 139: 105306. https://doi.org/10.1016/j.worlddev.2020.105306.
Jenkins, R. 2018. How China is reshaping the global economy: Development impacts in China and Latin America. Oxford: Oxford University Press.
Jenkins, R., & Edwards, L. 2015. Is China ‘crowding out’ South African exports of manufactures? The European Journal of Development Research, 27(5): 903–920.
Joseph, R. 2016. Pharmaceutical industry and public policy in post-reform India. Abingdon: Routledge.
Kahn, T. 2018. Pharma firm Ketlaphela has another shot at finding a partner. Business Live. March 15. https://www.businesslive.co.za/bd/companies/healthcare/2018-03-15-pharma-firm-ketlaphela-has-another-shot-at-finding-partner/. Accessed 27 November 2019.
Kahn, T. 2020. Drugmaker Cipla expands local manufacturing capacity. Business Live, October 24. Available from: https://www.businesslive.co.za/bd/companies/industrials/2019-10-24-drugmaker-cipla-expands-local-manufacturing-capacity/. Accessed: 13 October 2020.
Kaplan, W. & Laing, R. 2005. Local production of pharmaceuticals: Industrial policy and access to medicines. Health, Nutrition and Population (HNP) Discussion Paper. Washington, D.C.: The World Bank.
Kaplinsky, R., & Messner, D. 2008. Introduction: The impact of Asian Drivers on the developing world. World Development, 36(2): 197–209.
Kaplinsky, R., & Morris, M. 2015. Thinning and thickening: Productive sector policies in the era of global value chains. European Journal of Development Research, 28(4): 625–645.
Kaplinsky, R., Terheggen, A., & Tijaja, J. 2011. China as a final market: The Gabon timber and Thai cassava value chains. World Development, 39(7): 1177–1190.
Keet, J. 2010. Government won’t be blackmailed over ARVs, says Minister. Mail and Guardian, April 13. https://mg.co.za/article/2010-04-13-govt-wont-be-blackmailed-over-arvs-says-minister. Accessed 23 February 2020.
Krishnan, V. & Gahlot, M. 2015. Why South Africa’s health minister is so worried about India caving in to big pharma, Scroll.in, August 15. https://scroll.in/article/745344/why-south-africas-health-minister-is-so-worried-about-india-caving-in-to-big-pharma.
Krugman, P. 2008. Trade and wages, reconsidered. Brookings Papers on Economic Activity, Spring 103–154.
Kudlinski, A. 2011. Domestic manufacture of APIs. UNIDO Conference on Local Pharmaceutical Production in Africa. Cape Town. 06 April. Available from: https://gc21.giz.de/ibt/site/localpharma/ibt/AndreKudlinski_06-04.pdf. Accessed 21 July 2014.
Kudlinski, A. 2013. Harmonizing the national policies for healthcare, pharmaceutical industry and intellectual property: The South African experience. In F. M. Abbott, C. Correa, & P. Drahos (Eds.), Emerging markets and the world patent order. Cheltenham: Edward Elgar.
Low, M. & MacDonnell, S. 2019. HIV in SA: Seven graphs that tell the story. Spotlight. 18 July. Available from: https://www.spotlightnsp.co.za/2019/07/18/hiv-in-sa-seven-graphs-that-tell-the-story/.
Lundan, S. M. 2018. From the editor: Engaging international business scholars with public policy issues. Journal of International Business Policy, 1(1): 1–11.
Mackintosh, M., Banda, G., Tibandebage, P., & Wamae, W. (Eds.). 2015. Making Medicines in Africa: The Political Economy of Industrializing for Local Health. London: Palgrave Macmillan.
Maloney, C., & Segal, N. 2007. The growth potential of the pharmaceutical industry in South Africa. Johannesburg: Genesis Analytics.
Mayer, F., & Phillips, N. 2017. Outsourcing governance: States and the politics of a ‘global value chain world’. New Political Economy, 22(2): 134–152.
Moreira, M. 2007. Fear of China: Is there a future for manufacturing in Latin America? World Development, 35(3): 355–376.
Murphy, J., & Carmody, P. 2015. Africa’s information revolution: Technical regimes and production networks in South Africa and Tanzania. London: John Wiley & Sons.
NAPM (National Association of Pharmaceutical Manufacturers) (2010). Presentation to the Trade and Industry Portfolio Committee Hearings. Pretoria: Department of Trade and Industry.
Neilson, J., & Pritchard, B. 2009. Value chain struggles: Institutions and governance in the plantation districts of south India. Oxford: Wiley-Blackwell.
Njobeni, S. 2019. Aspen seals ARV deal with huge Indian supplier. Business Live, September 19. https://www.businesslive.co.za/bd/companies/healthcare/2019-09-19-aspen-seals-arv-deal-with-huge-indian-supplier/. Accessed 21 February 2020.
Palmer, E. 2012. Sandoz expanding capacity in South Africa. Fierce Pharma. November 29. https://www.fiercepharma.com/partnering/sandoz-expanding-capacity-south-africa. Accessed 07 March 2020.
Pasquali, G. 2020. When value chains go South: Upgrading in the Kenyan leather sector. Journal of World Business. https://doi.org/10.1016/j.jwb.2020.101161.
Pfizer South Africa. 2020. About us – Our history. https://www.pfizer.co.za/About#aboutpfizersection6. Accessed 05 March 2020.
Pharasi, B., et al. 2010. Medicines procurement reform in the public sector – Challenges and opportunities for improvement of medicines procurement in South Africa’s public sector. Pretoria: Department of Health, Republic of South Africa.
PharmaExec. 2016. Country Report: South Africa. http://www.pharmexec.com/country-report-south-africa-0. Accessed 21 February 2020.
Pike, A. 2020. Coping with deindustrialization in the global North and South. International Journal of Urban Sciences, 1–22.
Pipkin, S., & Fuentes, A. 2017. Spurred to upgrade: A review of triggers and consequences of industrial upgrading in the global value chain literature. World Development, 98: 536–554.
Prakash Sethi, S., & Williams, O. F. 2012. Economic imperatives and ethical values in global business: The South African experience and international codes today. Boston, Dordrecht, London: Kluwer Academic Publishers.
Ryan, M. 1983. Aspects of the history of organised pharmacy in South Africa, 1885-1946. Thesis submitted for Master of Arts in History, Cape Town: University of Cape Town.
Sanofi South Africa. 2020. About us, Sanofi Aventis South Africa. https://www.sanofi.co.za/en/about-us. Accessed 07 March 2020.
Shadlen, K. 2009. The politics of patents and drugs in Brazil and Mexico: The industrial bases of health policies. Comparative Politics, 42(1): 41–58.
Smith, A. 2015. The state, institutional frameworks and the dynamics of capital in global production networks. Progress in Human Geography, 39(3): 290–315.
Sprague, C., & Woolman, S. 2008. Aspen pharmacare. New York: United Nations Development Programme.
Staritz C., Gereffi G., & Cattaneo O. 2011. Editorial. International Journal of Technological Learning, Innovation and Development, 4(1/2/3): 1–12.
Steenkamp, W. F. J. 1979. The pharmaceutical industry in South Africa. South African Journal of Economics, 47(1): 75–89.
Suleman, F., & Gray, A. 2017. Pharmaceutical policy in South Africa. In Z.-U.-D. Babar (Ed.), Pharmaceutical policy in countries with developing healthcare systems. Cham: Springer International Publishing.
TIPS. 2016. Analysis of existing industrial policies and the state of implementation in South Africa. Pretoria: Trade and Industrial Policy Strategies. https://www.fes-southafrica.org/fileadmin/user_upload/TIPS_IP_REVIEW_FES-Revised_Final_Dec_2016_edit.pdf.
Tomlinson, C. 2020. In-depth: What ever happened to Ketlaphela? Spotlight. Available from: https://www.spotlightnsp.co.za/2020/06/05/in-depth-what-ever-happened-to-ketlaphela/. Accessed: 22 August 2020.
Tomlinson, C. & Low, M. 2012. Local production: Not a silver bullet. Spotlight. Available from: https://www.spotlightnsp.co.za/2012/06/10/local-production-not-a-silver-bullet-2/. Accessed: 26 November 2019.
Van Assche, A. 2018. From the editor: Steering a policy turn in international business – Opportunities and challenges. Journal of International Business Policy, 1(3–4): 117–127.
Vugigi, S., Thoithi, G. N., Ogaji, J. I., & Onuonga, S. O. 2017. Production capacity of the pharmaceutical manufacturing industry in Kenya. East and Central African Journal of Pharmaceutical Sciences, 20(1–3): 3–12.
Wade, R. 2003. What strategies are viable for developing countries today? The World Trade Organisation and the shrinking of development space. Review of International Political Economy, 10(4): 621–644.
Werner, M. 2020. Geographies of production II: Thinking through the state. Progress in Human Geography. https://doi.org/10.1177/0309132520911996.
Whitfield, L., Staritz, C., & Morris, M. 2020. Global value chains, industrial policy and economic upgrading in Ethiopia’s apparel sector. Development and Change, 51(4): 1018–1043.
Whittaker, D. H., Sturgeon, T., Okita, T., & Zhu, T. 2020. Compressed development: Time and timing in social and economic development. Oxford: Oxford University Press.
World Health Organisation (WHO). 2011. Local production and access to medicines in low- and middle-income countries: A literature review and critical analysis. Geneva: World Health Organization.
Wouters, O. J., Sandberg, D., Pillay, A., & Kanavos, P. 2019. The impact of pharmaceutical tendering on prices and market concentration in South Africa over a 14-year period. Social Science & Medicine, 220: 362–370.
Yeung, H. 2016. Strategic coupling: East Asian industrial transformation in the new global economy. Ithaca, NY: Cornell University Press.